1. Gankyrin as a potential therapeutic target for cancer
   Chongchong Wang et al, 2017, Invest New Drugs CrossRef
2. Overexpression of p28GANK accelerates the metastasis of oesophageal squamous cell carcinoma
   SHANHONG TANG et al, 2015 CrossRef
3. Single factors alone can induce mesenchymal-like morphology, but not promote full EMT in breast cancer cell lines with different hormone statuses
   Maria K. Tveitarås et al, 2017, Experimental Cell Research CrossRef
4. Gankyrin: a novel promising therapeutic target for hepatocellular carcinoma
   Parvin Zamani et al, 2017, Artificial Cells, Nanomedicine, and Biotechnology CrossRef
5. TGF-β1 signaling pathway serves a role in HepG2 cell regulation by affecting the protein expression of PCNA, gankyrin, p115, XIAP and survivin
   Xin-Hong Wang et al, 2017 CrossRef
6. null
   A. M. V. N. Prathyusha et al, 2017 CrossRef
7. Decreased E-Cadherin in MCF7 Human Breast Cancer Cells Forming Multicellular Spheroids Exposed to Simulated Microgravity
   Jayashree Sahana et al, 2018, Proteomics CrossRef
8. IL-37b suppresses epithelial mesenchymal transition in hepatocellular carcinoma by inhibiting IL-6/STAT3 signaling
   Xing-Yu Pu et al, 2018, Hepatobiliary & Pancreatic Diseases International CrossRef
9. The long non-coding RNA Linc-GALH promotes hepatocellular carcinoma metastasis via epigenetically regulating Gankyrin
   Xiaoliang Xu et al, 2019, Cell Death Dis CrossRef
10. MiR-605 represses PSMD10/Gankyrin and inhibits intrahepatic cholangiocarcinoma cell progression
    Jianwei Li et al, 2014 CrossRef
11. Clinicopathologic features and prognostic implications of Gankyrin protein expression in non-small cell lung cancer
    Wu-ping Wang et al, 2015, Pathology - Research and Practice CrossRef
12. Gankyrin regulates cell signaling network
    Xinxin Wang et al, 2016, Tumor Biol. CrossRef
13. The oncogene Gankyrin is expressed in testicular cancer and contributes to cisplatin sensitivity in embryonal carcinoma cells
    Maria E. Camacho-Moll et al, 2019, BMC Cancer CrossRef
14. POTEE promotes colorectal carcinoma progression via activating the Rac1/Cdc42 pathway
    Qiong Xu et al, 2020, Experimental Cell Research CrossRef
15. Gankyrin promotes epithelial-mesenchymal transition and metastasis in NSCLC through forming a closed circle with IL-6/ STAT3 and TGF-β/SMAD3 signaling pathway
    Wu-ping Wang et al, 2017, Oncotarget CrossRef
16. Identification of a covalent binder to the oncoprotein gankyrin using a NIR-Based OBOC screening method
    Marianne E. Maresh et al, 2021, RSC Adv. CrossRef
17. Gankyrin as Potential Biomarker for Colorectal Cancer With Occult Liver Metastases
    Chengxing Wang et al, 2021, Front. Oncol. CrossRef
18. Gankyrin: At the crossroads of cancer diagnosis, disease prognosis, and development of efficient cancer therapeutics
    Dharmendra Kashyap et al, 2021, Advances in Cancer Biology - Metastasis CrossRef
19. Small-Molecule Gankyrin Inhibition as a Therapeutic Strategy for Breast and Lung Cancer
    Dipti Kanabar et al, 2022, J. Med. Chem. CrossRef
20. Gankyrin inhibits ferroptosis through the p53/SLC7A11/GPX4 axis in triple-negative breast cancer cells
    Ming Lei et al, 2023, Sci Rep CrossRef
21. Synthesis and evaluation of 2,5-substituted pyrimidines as small-molecule gankyrin binders
    Dipti Kanabar et al, 2024, Future Medicinal Chemistry CrossRef